ID   UBA6_HUMAN              Reviewed;        1052 AA.
AC   A0AVT1; A6N8M7; B2RAV3; Q4W5K0; Q6UV21; Q86T78; Q86TC7; Q8N5T3;
AC   Q8N9E4; Q9H3T7; Q9NVC9;
DT   20-FEB-2007, integrated into UniProtKB/Swiss-Prot.
DT   28-NOV-2006, sequence version 1.
DT   10-MAY-2017, entry version 110.
DE   RecName: Full=Ubiquitin-like modifier-activating enzyme 6;
DE            Short=Ubiquitin-activating enzyme 6;
DE            EC=6.2.1.45 {ECO:0000250|UniProtKB:P22314};
DE   AltName: Full=Monocyte protein 4;
DE            Short=MOP-4;
DE   AltName: Full=Ubiquitin-activating enzyme E1-like protein 2;
DE            Short=E1-L2;
GN   Name=UBA6; Synonyms=MOP4, UBE1L2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), TISSUE SPECIFICITY, AND
RP   FUNCTION.
RX   PubMed=15202508; DOI=10.1093/abbs/36.3.227;
RA   Zhu H., Zhou Z.-M., Huo R., Huang X.-Y., Lu L., Lin M., Wang L.-R.,
RA   Zhou Y.-D., Li J.-M., Sha J.-H.;
RT   "Identification and characteristics of a novel E1 like gene nUBE1L in
RT   human testis.";
RL   Acta Biochim. Biophys. Sin. 36:227-234(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), VARIANT THR-224, FUNCTION,
RP   TISSUE SPECIFICITY, AND MUTAGENESIS OF CYS-625.
RX   PubMed=17597759; DOI=10.1038/nature05902;
RA   Jin J., Li X., Gygi S.P., Harper J.W.;
RT   "Dual E1 activation systems for ubiquitin differentially regulate E2
RT   enzyme charging.";
RL   Nature 447:1135-1138(2007).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Blood;
RA   Takayama K., Fujii Y., Ukai Y., Yoshimoto M.;
RT   "Molecular and biological characterization of a new ubiquitin-
RT   activating enzyme E1 like protein, MOP-4 which is highly expressed in
RT   human monocytes.";
RL   Submitted (MAY-1998) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 4), AND VARIANT
RP   THR-224.
RC   TISSUE=Hippocampus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT
RP   THR-224.
RC   TISSUE=Skeletal muscle;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 3).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   FUNCTION, INTERACTION WITH UBD, THIOESTER FORMATION, AND MUTAGENESIS
RP   OF CYS-625.
RX   PubMed=17889673; DOI=10.1016/j.molcel.2007.08.020;
RA   Chiu Y.-H., Sun Q., Chen Z.J.;
RT   "E1-L2 activates both ubiquitin and FAT10.";
RL   Mol. Cell 27:1014-1023(2007).
RN   [9]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [10]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-544, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-54; SER-301 AND SER-737,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   -!- FUNCTION: Activates ubiquitin by first adenylating its C-terminal
CC       glycine residue with ATP, and thereafter linking this residue to
CC       the side chain of a cysteine residue in E1, yielding a ubiquitin-
CC       E1 thioester and free AMP. Specific for ubiquitin, does not
CC       activate ubiquitin-like peptides. Differs from UBE1 in its
CC       specificity for substrate E2 charging. Does not charge cell cycle
CC       E2s, such as CDC34. Essential for embryonic development. Required
CC       for UBD/FAT10 conjugation. Isoform 2 may play a key role in
CC       ubiquitin system and may influence spermatogenesis and male
CC       fertility. {ECO:0000269|PubMed:15202508,
CC       ECO:0000269|PubMed:17597759, ECO:0000269|PubMed:17889673}.
CC   -!- CATALYTIC ACTIVITY: ATP + ubiquitin + [E1 ubiquitin-activating
CC       enzyme]-L-cysteine = AMP + diphosphate + S-ubiquitinyl-[E1
CC       ubiquitin-activating enzyme]-L-cysteine.
CC       {ECO:0000250|UniProtKB:P22314}.
CC   -!- PATHWAY: Protein modification; protein ubiquitination.
CC       {ECO:0000250|UniProtKB:P22314}.
CC   -!- SUBUNIT: Forms a thioester with UBD in cells stimulated with tumor
CC       necrosis factor-alpha (TNFa) and interferon-gamma (IFNg).
CC   -!- INTERACTION:
CC       Q6NT76:HMBOX1; NbExp=3; IntAct=EBI-5282516, EBI-2549423;
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1;
CC         IsoId=A0AVT1-1; Sequence=Displayed;
CC       Name=2; Synonyms=nUBE1L;
CC         IsoId=A0AVT1-2; Sequence=VSP_023083;
CC       Name=3;
CC         IsoId=A0AVT1-3; Sequence=VSP_023086, VSP_023087;
CC       Name=4;
CC         IsoId=A0AVT1-4; Sequence=VSP_023084, VSP_023085;
CC   -!- TISSUE SPECIFICITY: Widely expressed. Isoform 2 is predominantly
CC       expressed in testis with higher expression in adult testis than in
CC       fetal testis. {ECO:0000269|PubMed:15202508,
CC       ECO:0000269|PubMed:17597759}.
CC   -!- SIMILARITY: Belongs to the ubiquitin-activating E1 family.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA91824.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY359880; AAQ63403.1; -; mRNA.
DR   EMBL; EF623993; ABR25253.1; -; mRNA.
DR   EMBL; AB014773; BAB19785.1; -; mRNA.
DR   EMBL; AK001670; BAA91824.1; ALT_INIT; mRNA.
DR   EMBL; AK094969; BAC04463.1; -; mRNA.
DR   EMBL; AK314371; BAG37000.1; -; mRNA.
DR   EMBL; AL832015; CAD89908.1; -; mRNA.
DR   EMBL; AL832458; CAD89959.1; -; mRNA.
DR   EMBL; AC079880; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC096720; AAY40999.1; -; Genomic_DNA.
DR   EMBL; BC031637; AAH31637.1; -; mRNA.
DR   EMBL; BC126484; AAI26485.1; -; mRNA.
DR   EMBL; BC126486; AAI26487.1; -; mRNA.
DR   CCDS; CCDS3516.1; -. [A0AVT1-1]
DR   RefSeq; NP_060697.4; NM_018227.5. [A0AVT1-1]
DR   UniGene; Hs.212774; -.
DR   ProteinModelPortal; A0AVT1; -.
DR   SMR; A0AVT1; -.
DR   BioGrid; 120529; 76.
DR   DIP; DIP-57633N; -.
DR   IntAct; A0AVT1; 5.
DR   MINT; MINT-1195700; -.
DR   STRING; 9606.ENSP00000313454; -.
DR   BindingDB; A0AVT1; -.
DR   ChEMBL; CHEMBL2321622; -.
DR   iPTMnet; A0AVT1; -.
DR   PhosphoSitePlus; A0AVT1; -.
DR   BioMuta; UBA6; -.
DR   EPD; A0AVT1; -.
DR   MaxQB; A0AVT1; -.
DR   PaxDb; A0AVT1; -.
DR   PRIDE; A0AVT1; -.
DR   DNASU; 55236; -.
DR   Ensembl; ENST00000322244; ENSP00000313454; ENSG00000033178. [A0AVT1-1]
DR   Ensembl; ENST00000420827; ENSP00000399234; ENSG00000033178. [A0AVT1-3]
DR   GeneID; 55236; -.
DR   KEGG; hsa:55236; -.
DR   UCSC; uc003hdg.5; human. [A0AVT1-1]
DR   CTD; 55236; -.
DR   GeneCards; UBA6; -.
DR   H-InvDB; HIX0031574; -.
DR   H-InvDB; HIX0120163; -.
DR   HGNC; HGNC:25581; UBA6.
DR   HPA; HPA037001; -.
DR   MIM; 611361; gene.
DR   neXtProt; NX_A0AVT1; -.
DR   OpenTargets; ENSG00000033178; -.
DR   PharmGKB; PA162407690; -.
DR   eggNOG; KOG2012; Eukaryota.
DR   eggNOG; COG0476; LUCA.
DR   GeneTree; ENSGT00390000016689; -.
DR   HOVERGEN; HBG054199; -.
DR   InParanoid; A0AVT1; -.
DR   KO; K10699; -.
DR   OMA; WLSWTAQ; -.
DR   OrthoDB; EOG091G0130; -.
DR   PhylomeDB; A0AVT1; -.
DR   TreeFam; TF300586; -.
DR   BRENDA; 6.2.1.B9; 2681.
DR   Reactome; R-HSA-8866652; Synthesis of active ubiquitin: roles of E1 and E2 enzymes.
DR   Reactome; R-HSA-983168; Antigen processing: Ubiquitination & Proteasome degradation.
DR   UniPathway; UPA00143; -.
DR   ChiTaRS; UBA6; human.
DR   GeneWiki; UBE1L2; -.
DR   GenomeRNAi; 55236; -.
DR   PRO; PR:A0AVT1; -.
DR   Proteomes; UP000005640; Chromosome 4.
DR   Bgee; ENSG00000033178; -.
DR   ExpressionAtlas; A0AVT1; baseline and differential.
DR   Genevisible; A0AVT1; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:LIFEdb.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0019780; F:FAT10 activating enzyme activity; IMP:UniProtKB.
DR   GO; GO:0004839; F:ubiquitin activating enzyme activity; IEA:Ensembl.
DR   GO; GO:0021764; P:amygdala development; IEA:Ensembl.
DR   GO; GO:0060996; P:dendritic spine development; IEA:Ensembl.
DR   GO; GO:0021766; P:hippocampus development; IEA:Ensembl.
DR   GO; GO:0007612; P:learning; IEA:Ensembl.
DR   GO; GO:0007626; P:locomotory behavior; IEA:Ensembl.
DR   GO; GO:0016567; P:protein ubiquitination; IMP:UniProtKB.
DR   GO; GO:0042787; P:protein ubiquitination involved in ubiquitin-dependent protein catabolic process; IEA:Ensembl.
DR   GO; GO:0006511; P:ubiquitin-dependent protein catabolic process; IMP:UniProtKB.
DR   InterPro; IPR032420; E1_4HB.
DR   InterPro; IPR032418; E1_FCCH.
DR   InterPro; IPR000594; ThiF_NAD_FAD-bd.
DR   InterPro; IPR018965; Ub-activating_enz_E1_C.
DR   InterPro; IPR019572; UBA_E1_Cys.
DR   InterPro; IPR018075; UBQ-activ_enz_E1.
DR   InterPro; IPR000011; UBQ/SUMO-activ_enz_E1-like.
DR   Pfam; PF16191; E1_4HB; 1.
DR   Pfam; PF16190; E1_FCCH; 1.
DR   Pfam; PF09358; E1_UFD; 1.
DR   Pfam; PF00899; ThiF; 2.
DR   Pfam; PF10585; UBA_e1_thiolCys; 1.
DR   PRINTS; PR01849; UBIQUITINACT.
DR   SMART; SM00985; UBA_e1_C; 1.
DR   SUPFAM; SSF69572; SSF69572; 2.
DR   TIGRFAMs; TIGR01408; Ube1; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative splicing; ATP-binding; Complete proteome;
KW   Ligase; Nucleotide-binding; Phosphoprotein; Polymorphism;
KW   Reference proteome; Ubl conjugation pathway.
FT   CHAIN         1   1052       Ubiquitin-like modifier-activating enzyme
FT                                6.
FT                                /FTId=PRO_0000277797.
FT   NP_BIND     569    570       ATP. {ECO:0000250|UniProtKB:P22515}.
FT   ACT_SITE    625    625       Glycyl thioester intermediate.
FT                                {ECO:0000255|PROSITE-ProRule:PRU10132}.
FT   BINDING     470    470       ATP; via amide nitrogen.
FT                                {ECO:0000250|UniProtKB:P22515}.
FT   BINDING     497    497       ATP. {ECO:0000250|UniProtKB:P22515}.
FT   BINDING     508    508       ATP. {ECO:0000250|UniProtKB:P22515}.
FT   BINDING     521    521       ATP. {ECO:0000250|UniProtKB:P22515}.
FT   MOD_RES       1      1       N-acetylmethionine.
FT                                {ECO:0000244|PubMed:19413330}.
FT   MOD_RES      54     54       Phosphothreonine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     301    301       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     544    544       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     729    729       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q8C7R4}.
FT   MOD_RES     737    737       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   VAR_SEQ       1    474       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:15202508}.
FT                                /FTId=VSP_023083.
FT   VAR_SEQ     321    340       APLEIHTAMLALDQFQEKYS -> VNKHFAGLREAAESEMR
FT                                ISE (in isoform 4).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_023084.
FT   VAR_SEQ     341   1052       Missing (in isoform 4).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_023085.
FT   VAR_SEQ     369    389       PDVNADIVHWLSWTAQGFLSP -> VTIEIYGCPNICLLIH
FT                                KCSVY (in isoform 3).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_023086.
FT   VAR_SEQ     390   1052       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_023087.
FT   VARIANT     224    224       A -> T (in dbSNP:rs10010188).
FT                                {ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:17597759,
FT                                ECO:0000269|PubMed:17974005}.
FT                                /FTId=VAR_030594.
FT   MUTAGEN     625    625       C->A,S: Impairs ubiquitin activation.
FT                                {ECO:0000269|PubMed:17597759,
FT                                ECO:0000269|PubMed:17889673}.
FT   CONFLICT     14     14       E -> K (in Ref. 5; CAD89908).
FT                                {ECO:0000305}.
FT   CONFLICT    140    140       V -> A (in Ref. 5; CAD89908).
FT                                {ECO:0000305}.
FT   CONFLICT    197    197       C -> Y (in Ref. 4; BAC04463).
FT                                {ECO:0000305}.
FT   CONFLICT    234    234       N -> D (in Ref. 5; CAD89959).
FT                                {ECO:0000305}.
FT   CONFLICT    297    297       V -> A (in Ref. 4; BAC04463).
FT                                {ECO:0000305}.
FT   CONFLICT    645    645       F -> V (in Ref. 1; AAQ63403).
FT                                {ECO:0000305}.
FT   CONFLICT    803    803       Q -> H (in Ref. 4; BAA91824).
FT                                {ECO:0000305}.
FT   CONFLICT    821    821       E -> G (in Ref. 5; CAD89959).
FT                                {ECO:0000305}.
FT   CONFLICT    868    868       L -> P (in Ref. 5; CAD89908).
FT                                {ECO:0000305}.
FT   CONFLICT    905    905       V -> G (in Ref. 1; AAQ63403).
FT                                {ECO:0000305}.
FT   CONFLICT    909    909       M -> K (in Ref. 5; CAD89959).
FT                                {ECO:0000305}.
FT   CONFLICT    920    920       A -> V (in Ref. 3; BAB19785).
FT                                {ECO:0000305}.
SQ   SEQUENCE   1052 AA;  117970 MW;  9F9C70EABA750A71 CRC64;
     MEGSEPVAAH QGEEASCSSW GTGSTNKNLP IMSTASVEID DALYSRQRYV LGDTAMQKMA
     KSHVFLSGMG GLGLEIAKNL VLAGIKAVTI HDTEKCQAWD LGTNFFLSED DVVNKRNRAE
     AVLKHIAELN PYVHVTSSSV PFNETTDLSF LDKYQCVVLT EMKLPLQKKI NDFCRSQCPP
     IKFISADVHG IWSRLFCDFG DEFEVLDTTG EEPKEIFISN ITQANPGIVT CLENHPHKLE
     TGQFLTFREI NGMTGLNGSI QQITVISPFS FSIGDTTELE PYLHGGIAVQ VKTPKTVFFE
     SLERQLKHPK CLIVDFSNPE APLEIHTAML ALDQFQEKYS RKPNVGCQQD SEELLKLATS
     ISETLEEKPD VNADIVHWLS WTAQGFLSPL AAAVGGVASQ EVLKAVTGKF SPLCQWLYLE
     AADIVESLGK PECEEFLPRG DRYDALRACI GDTLCQKLQN LNIFLVGCGA IGCEMLKNFA
     LLGVGTSKEK GMITVTDPDL IEKSNLNRQF LFRPHHIQKP KSYTAADATL KINSQIKIDA
     HLNKVCPTTE TIYNDEFYTK QDVIITALDN VEARRYVDSR CLANLRPLLD SGTMGTKGHT
     EVIVPHLTES YNSHRDPPEE EIPFCTLKSF PAAIEHTIQW ARDKFESSFS HKPSLFNKFW
     QTYSSAEEVL QKIQSGHSLE GCFQVIKLLS RRPRNWSQCV ELARLKFEKY FNHKALQLLH
     CFPLDIRLKD GSLFWQSPKR PPSPIKFDLN EPLHLSFLQN AAKLYATVYC IPFAEEDLSA
     DALLNILSEV KIQEFKPSNK VVQTDETARK PDHVPISSED ERNAIFQLEK AILSNEATKS
     DLQMAVLSFE KDDDHNGHID FITAASNLRA KMYSIEPADR FKTKRIAGKI IPAIATTTAT
     VSGLVALEMI KVTGGYPFEA YKNCFLNLAI PIVVFTETTE VRKTKIRNGI SFTIWDRWTV
     HGKEDFTLLD FINAVKEKYG IEPTMVVQGV KMLYVPVMPG HAKRLKLTMH KLVKPTTEKK
     YVDLTVSFAP DIDGDEDLPG PPVRYYFSHD TD
//
